Wellness Radar Subscribe
Reference library

The encyclopedia, fully cited.

Drug profiles, peptide entries, supplement summaries, lab-range interpretation, bioregulators, and the glossary that demystifies every acronym. Each entry is a self-contained reference — pharmacology, dosing, contraindications, evidence, cost — cross-linked to long reads and tools.

Drug profiles, peptide encyclopedia, supplement database, lab interpretation — Wellness Radar reference library
● Live
01 / Drug profile

Semaglutide

Ozempic, Wegovy, Rybelsus. GLP-1 receptor agonist. Pharmacology, dosing, contraindications, cost, off-label use.

Read profile →
● Live
02 / Encyclopedia

Peptide Encyclopedia

90+ profiles. Healing, growth, signaling, immune, cognitive, longevity peptides — all cited, all tiered.

Open encyclopedia →
● Live
03 / Drug profile

Tirzepatide

Mounjaro, Zepbound. Dual GIP/GLP-1 receptor agonist. Pharmacology, dosing, cost, head-to-head with semaglutide.

Read profile →
● Live
04 / Supplements

Supplement Database

Mechanism, evidence tier, dosing, interactions. Honest verdicts — what works, what doesn't, what's marketing.

Open database →
● Live
05 / Labs

Lab Interpretation

Reference ranges in plain English. What HbA1c, fasting insulin, ApoB, hsCRP, ferritin, and the rest actually mean.

Open lab guide →
● Live
06 / Bioregulators

Khavinson Bioregulators

All 40 short peptides decoded. Tissue-specificity, evidence base, regulatory status, sourcing realities.

Read reference →
● Live
07 / Glossary

Glossary

Every acronym, every mechanism term, every protocol abbreviation — defined on first reference.

Open glossary →
● Live
08 / Drug profile

Metformin

The biguanide. T2D first-line and the TAME off-label longevity case. AMPK mechanism, dosing, B12 caveat, exercise trade-off.

Read profile →
● Live
09 / Drug profile

Rapamycin

mTOR inhibitor. Intermittent dosing rationale, the immune trade-off, what longevity-medicine clinics actually prescribe.

Read profile →
● Live
10 / Drug profile

Retatrutide

Triple agonist — GLP-1 + GIP + glucagon. Phase 3 readouts, the efficacy ceiling shift, what to watch.

Read profile →
● Live
11 / Drug profile

Liraglutide

First-gen GLP-1 (Saxenda, Victoza). Daily dosing, lower efficacy vs. sema/tirz, where it still has a niche.

Read profile →
● Live
12 / Drug profile

Orforglipron

Oral small-molecule GLP-1. Non-peptide chemistry, food-independent dosing, Phase 3 readouts.

Read profile →
● Live
13 / Drug profile

CagriSema

Cagrilintide + semaglutide combo. Amylin co-agonism, REDEFINE trial outcomes, the additive efficacy case.

Read profile →
● Live
14 / Supplement

Berberine

"Nature's Ozempic" framing — honestly compared. AMPK mechanism, the real evidence, the GI side-effect reality.

Read profile →
● Live
15 / Supplement

Creatine

Beyond strength — the cognitive RCT data (vegetarians + sleep-deprived strongest), monohydrate dosing, the safety record.

Read profile →
● Live
16 / Drug profile

Modafinil

Wakefulness agent. Mechanism uncertainty, on-label vs. off-label, abuse-liability data, drug interactions.

Read profile →
● Live
17 / Supplement

Melatonin

The OTC dose problem. Why 0.3–0.5 mg is physiologic, melatonin as chronobiotic vs. hypnotic, DSPS use case.

Read profile →
● Live
18 / Test

Biological Age Tests

DNA methylation clocks compared — Horvath, PhenoAge, GrimAge, DunedinPACE. What each measures, intervention-responsiveness.

Read reference →
The Brief · Free · Weekly

Get the brief. Sunday morning.

One honest research email per week. New peptide data, protocol updates, what's hype vs. signal. Cited.

No spam. One-click unsubscribe.